Description:
Gelofulsine is a colloidal plasma substitute used for the treatment of shock, hypovolemia (low blood volume), and other conditions that require volume replacement therapy. It is used to expand blood volume in patients who have lost blood or fluid due to surgery, trauma, or burns. Gelofulsine contains modified gelatin, which acts as a plasma expander.

Prescription:

• Prescription required.

Dosage:

• The dosage depends on the patient’s condition, weight, and severity of fluid loss.
• Typically, 500mL is infused intravenously over a period as determined by the healthcare provider.
• Common dosage guidelines: 500-1000mL of Gelofulsine may be administered for patients with significant fluid loss, depending on the clinical situation.

Therapeutic Category:

• Plasma substitute
• Colloidal volume expander

Active Ingredients/Composition:

• Modified Gelatin
• Contains electrolytes (sodium, chloride, etc.) to maintain the osmotic balance.

Variant:

• 500mL intravenous solution.

Consume Type:

• Intravenous (IV) infusion.

Directions/Usage:

• For intravenous use only.
• Administered by a healthcare professional via an IV line.
• The volume and rate of infusion depend on the clinical condition of the patient and the doctor’s instructions.
• Use under medical supervision to monitor for side effects such as allergic reactions and fluid overload.

Common Side Effects:

• Allergic reactions (e.g., rash, fever, urticaria)
• Hypervolemia (excessive blood volume)
• Fluid overload
• Electrolyte imbalances
• Dyspnea (difficulty breathing)
• Nausea and vomiting
• Hypertension (high blood pressure)

Package Type:

• 500mL IV solution in a sterile, sealed bottle.

Storage Advice:

• Store in a cool, dry place, away from direct sunlight.
• Keep at room temperature (15-25°C).
• Do not freeze.
• Use within the recommended shelf-life from the manufacturing date.
• Discard unused solution after opening or after a prescribed period.

Safety Advice:

• Allergic Reactions: Rare but serious allergic reactions may occur. If signs of allergy appear (e.g., rash, difficulty breathing), discontinue use and seek medical attention immediately.
• Fluid Overload: Monitor closely for signs of fluid overload, especially in patients with heart or kidney issues.
• Electrolyte Imbalance: Regular monitoring of electrolytes and blood pressure is advised during and after administration.
• Pregnancy and Breastfeeding: Consult with a healthcare provider before use during pregnancy or breastfeeding.
• Kidney and Heart Disease: Use with caution in patients with pre-existing kidney or heart conditions.

Product Substitutes:

• Haemaccel
• Plasmalyte
• Voluven
• Dextran 40
• Ringer’s Lactate

Manufacturer/Marketer:

• Pharmaceutical companies

Country of Origin:

• India